Acadia proposes $150M in senior unsecured notes due 2021 Acadia Healthcare Organization, Inc. today announced that it’s proposing to issue $150 million in senior unprotected notes credited 2021 in a private offering that is exempt from the registration requirements of the Securities Take action of 1933, as amended . The ongoing business intends to use the net proceeds from the offering for general corporate purposes, which may include acquisitions What class of antibiotic is clavamox? . The Notes are to be offered only to qualified institutional customers in reliance on Rule 144A beneath the Securities Take action and beyond your United States only to non-U.S. Persons pursuant to Regulation S.
Acasti receives conditional authorization for listing of class A shares on TSX-Venture Neptune Systems & Bioressources Inc. Acasti has received conditional acceptance from the Exchange for the listing of its Class A share on the TSX-Venture . Acasti’s management expects to waive all circumstances with respect to the Listing prior to March 21, 2011. A complete press release will be issued by Acasti and Neptune at the time of the Listing, providing overview disclosure of the Listing and any related deal.